Biotech News Oncology Phase 1 May 31, 2025 Iksuda Begins First-in-Human Trial of CD19-Targeting ADC for B Cell Lymphoma Newcastle-based Iksuda Therapeutics has announced a key clinical milestone with the dosing of the first… Read More